Hongli X. Zhang

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, 300020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Efficacy and safety of allogeneic hematopoietic stem cell transplantation for the treatment of primary myelofibrosis

Efficacy and safety of allogeneic hematopoietic stem cell transplantation for the treatment of primary myelofibrosis

Journal: Zhonghua yi xue za zhi

Published: November 29, 2023

Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation

Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: June 25, 2023

Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis

Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: November 17, 2021

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.

Journal: Leukemia & lymphoma

Published: May 07, 2019

Analysis on trend of leukemia mortality from 1999 to 2015 in Tianjin, China

Analysis on trend of leukemia mortality from 1999 to 2015 in Tianjin, China

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: March 08, 2019

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.

Journal: British journal of haematology

Published: March 06, 2019

The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?

The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?

Journal: British journal of haematology

Published: December 02, 2017

Effect and mechanism of down-regulated expression of EZH2 on the invasion ability of leukemic cell HL-60 cells

Effect and mechanism of down-regulated expression of EZH2 on the invasion ability of leukemic cell HL-60 cells

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 31, 2017

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.

Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.

Journal: Blood cancer journal

Published: September 06, 2017

Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes.

Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes.

Journal: Genes, chromosomes & cancer

Published: August 21, 2017

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis.

Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis.

Journal: Blood cancer journal

Published: December 10, 2016

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.

Journal: Oncotarget

Published: August 26, 2016

Showing 1-12 of 34

Last Updated: 09/26/2026